Villalas, Cressa .

HRN: 28-55-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
CEFUROXIME 500MG (TAB)
03/06/2026
03/13/2026
PO
500
Bid
Uti
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: